Matches in Nanopublications for { ?s ?p "[BRAF mutation testing may also add additional information for differential diagnosis of primary brain tumors in selected situations, e.g., for differentiation of anaplastic pleomorphic xanthoastrocytoma (BRAF V600E mutation in 65%) from glioblastoma (BRAF V600E mutation in < 5%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP896554.RAAmSX5nJ2SOIF5FATDoNWV4VqKvyR4RTCj25zQWlaQOQ130_assertion description "[BRAF mutation testing may also add additional information for differential diagnosis of primary brain tumors in selected situations, e.g., for differentiation of anaplastic pleomorphic xanthoastrocytoma (BRAF V600E mutation in 65%) from glioblastoma (BRAF V600E mutation in < 5%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896554.RAAmSX5nJ2SOIF5FATDoNWV4VqKvyR4RTCj25zQWlaQOQ130_provenance.
- NP565901.RAiI6jMxYgGQxg9nZ31VerNMq0OwVVJztuxCEPrr-vxSQ130_assertion description "[BRAF mutation testing may also add additional information for differential diagnosis of primary brain tumors in selected situations, e.g., for differentiation of anaplastic pleomorphic xanthoastrocytoma (BRAF V600E mutation in 65%) from glioblastoma (BRAF V600E mutation in < 5%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565901.RAiI6jMxYgGQxg9nZ31VerNMq0OwVVJztuxCEPrr-vxSQ130_provenance.